Decline in Estrogen Levels and Its Impact on Muscle Strength in Elderly Women: A Systematic Review
DOI:
https://doi.org/10.26911/theijmed.2024.09.04.13Abstract
Background: In the musculoskeletal system, old age is closely related to a decline in muscle strength. Decreased muscle strength in women is caused by the influence of changes in estrogen hormone levels. Several studies were conducted to see how estrogen affects muscle mass, muscle function, muscle damage, muscle regeneration, inflammation in the body, mitochondrial funct¬ion, and substrate metabolism. Therefore, the study was carried out with the aim of conducting further study focusing on estrogen on muscle strength in elderly women.
Subjects and Method: The study was conducted with a systematic review design. The study was carried out in accordance using PRISM guidelines with the PICO formula. Population: elderly women, Intervention: estrogen hormone, Outcome: muscle weakness. Article searches were carried out through several databases, namely PubMed, Cochrane Library, Scopus Database, and Physio-therapy Evidence Database (PEDro) with the keywords: estrogen OR "estrogen hormone" OR "muscle strength" OR "risk of falls" OR "menopause" OR "women elderly." Risk of bias assessment was carried out according to the study design of each article.
Results: There were 10 articles involved in this study. The article has a cross-sectional and longitudinal study design. Articles had a low and medium risk of bias assessment. 6 articles stated that there was a relationship between changes in estrogen hormone levels and muscle weakness. 4 articles stated that there was no relationship between changes in estrogen hormone levels and muscle weakness.
Conclusion: There is a inconsistent relationship between estrogen levels and muscle strength in elderly women.
Keywords:
estrogen hormone, muscle weakness, elderly women, menopausal ageReferences
Baylis D, Bartlett DB, Syddall HE, Ntani G, Gale CR, Cooper C, Lord JM, et al. (2013). Immune-Endocrine Bio-markers as Predictors of Frailty and Mortality: 10-year Longitudinal Study in Community-Dwelling Older People. Age (Dordr). 35(3):963-71. doi: 10.1007/s11357-012-9396-8.
Bochud M, Ponte B, Pruijm M, Ackermann D, Guessous I, Ehret G, Escher G, et al. (2019). Urinary sex steroids and glucocorticoid hormones are asso-ciated with muscle mass and strength in healthy adults. J Clin Endocrinol Metab. 104(6):2195-2215. doi: 10.12-10/jc.2018-01942.
Cappola AR, Xue QL, Fried LP (2009). Multiple hormonal deficiencies in anabolic hormones are found in frail older women: the Women's Health and Aging studies. J Gerontol A Biol Sci Med Sci. 64(2):243-8. doi: 10.10-93/gerona/gln026.
Carcaillon L, García-García FJ, Tresguerres JA, Gutiérrez Avila G, Kireev R, Rodríguez-Mañas L (2012). Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the toledo study for healthy aging. J Clin Endocrinol Metab. 97(8):2898-906. doi: 10.1210/jc.2012-1271.
Carter AE, Merriam S. 2023. Menopause. Med Clin North Am. 107(2):199-212. doi: 10.1016/j.mcna.2022.10.003.
Chagas EFB, Bonfim MR, Turi BC, Bron-dino NCM, Monteiro HL (2017). Effect of moderate-intensity exercise on inflammatory markers among post- menopausal women. J Phys Act Health. 14:479-485. Doi: 10.1123/jp-ah.2016-0319.
Critchlow AJ, Hiam D, Williams R, Scott D, Lamon S. (2023). The role of estrogen in female skeletal muscle aging: A systematic review. Maturity.178:107-844. doi: 10.1016/j.maturitas.2023.107844.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, et al. (2019). Sarcopenia: Revised european consensus on definition and diagnosis. Age Ageing. 48:16–31. doi: 10.1093/ageing/afy169.
Cui J, Shen Y, Li C (2013). Estrogen syn-thesis and signaling pathways during aging from periphery to brain. Trends Mol. Med. 19 (3): 197–209, doi: 10.1016/j.molmed.2012.12.007.
Fang X, Shi J, Song X, Mitnitski A, Tang Z, Wang C, Yu P, Rockwood K (2012). And mortality in older Chinese adults: results from the beijing longitudinal study of aging. J Nutr Health. 16:903-907. doi:10.1007/s12603-012-0368-6
Ferrucci L, Fabbri E (2018). Inflammage-ing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 15(9):505-522. doi: 10.1038/s41569-018-0064-2.
Frontera AR, Zayas A, Rodriguez N (2014). A comprehensive guide to geriatric rehabilitation (Third Edition). Chur-chill Livingstone. 10-13. Doi:10.1016/B978-0-7020-4588-2.00002-4.
Frontera, Walter. (2014). Physical activity and rehabilitation in elderly. Springer International Publishing AG. DOI: 10.1007/978-3-319-57406-6_1.
Garcia-Garcia FJ, Gutierrez Avila G, Alfaro-Acha A, Amor Andres MS, De Los Angeles de la Torre Lanza M, Escribano Aparicio MV, Humanes Aparicio S, et al. (2011). The prevalence of frailty syndrome in an older population from Spain. The Toledo Study for Healthy Aging. J Nutr Health Aging 15: 852–856. Doi: 10.1007/s12603-011-0075-8.
Gariballa S, Alessa A (2017). Impact of poor muscle strength on clinical and service outcomes of older people during both acute illness and after recovery. BMC Geriatr. 7; 17(1):123. doi: 10.1186/s12877-017-0512-6.
Guligowska A, Chrzastek Z, Pawlikowski M, Pigłowska M, Pisarek H, Winczyk K, Kostka T (2021). Gonadotropins at advanced age - perhaps they are not so bad? correlations between gona-dotropins and sarcopenia indicators in older adults. Front Endocrinol (Lausanne). 24(12):797243. doi: 10.3389/fendo.2021.797243.
Hamilton KJ, Hewitt SC, Arao Y, Korach KS (2017). Estrogen hormone biology. Curr Top Dev Biol.125:109-146. doi: 10.1016/bs.ctdb.2016.12.-005.
Hubbard RE, O'Mahony MS, Savva GM, Calver BL, Woodhouse KW. (2009). Inflammation and frailty measures in older people. J Cell Mol Med. 13(9B): 3103-9. doi: 10.1111/j.1582-4934.20-09.00733.x.
Janssen I, Heymsfield SB, Ross R (2002). Low relative skeletal muscle mass (sarcopenia) in older persons is asso-ciated with functional impairment and physical disability. J Am Geriatr Soc. 50 (5):889–896, doi: 10.1046/-j.1532- 5415.2002.50216.x.
Kong SH, Kim JH, Lee JH, Hong AR, Shin CS, Cho NH (2019). Dehydroepiand-rosterone sulfate and free testosterone but not estradiol are related to muscle strength and bone microarchitecture in older adults. Calcif Tissue Int. 105(3): 285-293. doi: 10.1007/s00223-019-00566-5..
Lowe DA, Baltgalvis KA, Greising SM (2010). Mechanisms behind estro-gen's beneficial effect on muscle strength in females. Exerc Sport Sci Rev. 38(2):61-7. doi: 10.1097/JES.0-b013e3181d496bc.
Liu P, Ji Y, Yuen T, Rendina-Ruedy E, DeMambro VE, Dhawan S, Abu-Amer W, et al. (2017). Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature. 546 (7656): 107-112. doi: 10.1038/nature-22342.
Ministry of Health and Family Welfare, Government of India (2020). National Programme for Health Care of the Elderly (NPHCE). Available from: https://main.mohfw.gov.in/organi-sation/Departments-of-Health-and-Family-Welfare/national-program-me-health-care-elderly-nphce. Accessed 5 March 2020.
Montesanto A, De Rango F, Pirazzini C (2017). Demographic, genetic and phenotypic characteristics of centenarians in Italy: Focus on gender differences. Mech Ageing Dev. 165: 68–74. Team: S0047637416302585
Park YM, Jankowski CM, Ozemek C, Hildreth KL, Kohrt WM, Moreau KL (2020). Appendicular lean mass is lower in late compared with early perimenopausal women: potential role of FSH. J Appl Physiol (1985). 128(5): 1373-1380. doi: 10.1152/japplphysiol.00315.2019.
Payne AH, Hales DB. (2004). Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 25(6):947-70. doi: 10.1210/er.2003-0030.
Pesonen H, Laakkonen EK, Hautasaari P, Aukee P, Kovanen V, Sipilä S, Finni T, et al. (2021). Perimenopausal Women Show Modulation of Excitatory and Inhibitory Neuromuscular Mechanisms. BMC Womens Health. 21(1): 133. doi: 10.1186/s12905-021-01275-8.
Rolland YM, Perry HM, Patrick P, Banks WA, Morley JE (2007). Loss of appendicular muscle mass and loss of muscle strength in young postmeno-pausal women. J Gerontol A Biol Sci Med Sci. 62(3):330-5. doi: 10.1093/-gerona/62.3.330.
Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD. (1999). Midlife Hand Grip Strength as a Predictor of Old Age Disability. Jama. 281:558–60. doi: 10.1001/jama.281.6.558
Rathnayake N, Alwis G, Lenora J, Lekam-wasam S (2021). Factors Associated with Measures of Sarcopenia in Pre and Postmenopausal Women. BMC Womens Health. 21(1):5. doi: 10.11-86/s12905-020-01153-9.
Tom SE, Adachi JD, Anderson FA Jr, Boonen S, Chapurlat RD, Compston JE, Cooper C et al. (2013). Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women. J Am Geriatr Soc. 61:327-334. doi: 10.1111/jgs.12146.
Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, Simonsick EM, et al. (2005). Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons, J.Gerontol. A Biol. Sci. Med. Sci. 60 (3): 324–333, doi: 10.-1093/gerona/60.3.324.
Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, Simonsick EM, et al. (2005). Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons, J.Gerontol. A Biol Sci Med Sci. 60 (3): 324–333, doi: 10.10-93/gerona/60.3.324.
Wiik A, Ekman M, Johansson O, Jansson E, Esbjo rnsson M. (2009). Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue, Histochem. CellBiol. 131 (2): 181–189, doi: 10.1007/s00418-008-0512-x.
Yanagita I, Fujihara Y, Kitajima Y, Tajima M, Honda M, Kawajiri T, Eda T. (2019). A High Serum Cortisol/ DHEA-S Ratio Is a Risk Factor for Sarcopenia in Elderly Diabetic Pati-ents. J Endocr Soc. (4):801-813. doi: 10.1210/js.2018-00271.
